Clinicians are sometimes faced with some limitations that lead to misdiagnosis and patient uncertainty. QP-Prostate® - the only tool trained with both systematic and targeted biopsies - addresses this problem by increasing sensitivity from 79.8% up to 90.4%. See how QP-Prostate® can improve your practice: book a demo with our team today! https://lnkd.in/d67y-mqn #ProstateCancer #ProstateHealth #MensHealth #ProstateHealthAwarenessMonth
Quibim
Investigación biotecnológica
Valencia/València, Comunidad Valenciana / Comunitat Valenciana 11.481 seguidores
Transforming imaging data into actionable predictions
Sobre nosotros
En Quibim diseñamos herramientas pioneras que desbloquean datos de imagen para mejorar los resultados de los pacientes. Nuestro objetivo principal es la aplicación de técnicas de IA a imágenes médicas de RM, TC y PET para desbloquear nuevos datos que puedan transformarse en predicciones accionables.
- Sitio web
-
https://quibim.com/
Enlace externo para Quibim
- Sector
- Investigación biotecnológica
- Tamaño de la empresa
- De 51 a 200 empleados
- Sede
- Valencia/València, Comunidad Valenciana / Comunitat Valenciana
- Tipo
- De financiación privada
- Fundación
- 2015
- Especialidades
- imaging biomarkers, precision medicine, image analysis, artificial intelligence, quantification, oncology, cloud computing, companion diagnostics, immunotherapy, digital biomarkers, virtual biopsy, drug programmes, data repositories y CAR-T cells
Ubicaciones
-
Principal
Avenida de Aragón, 30
13th floor, Office I-J
Valencia/València, Comunidad Valenciana / Comunitat Valenciana 46026, ES
-
230 Park Ave Spaces
Office 423
New York, New York 10169 , US
-
Calle de Alfonso XII, 62
3° floor
Madrid, Community of Madrid 28014, ES
-
Science Park
Cambridge, England CB4 0GA, GB
Empleados en Quibim
-
Mark Wittenberg
Seasoned Business Development Leader / Life Sciences / Clinical Imaging
-
Pierre Socha
Partner @ Amadeus Capital
-
Erik R. Ranschaert, MD, PhD
Visiting Professor at Ghent University. KOL in AI for Radiology, Radiologist, Scientist, Teacher, Advisor and Entrepreneur.
-
Luis Bosque
CTO at Quibim
Actualizaciones
-
As the healthcare landscape rapidly evolves, we're eager to hear your thoughts on radiomics, a pioneering field within #PrecisionMedicine. How knowledgeable and interested do you think healthcare professionals are in radiomics? Join the conversation, and let's explore the perspectives in our field on this transformative technology! #Radiomics #AIInHealth #InnovationInHealth #Quibim
El contenido no está disponible aquí
Accede a este contenido y mucho más en la aplicación de LinkedIn
-
August saw a lot of interesting news and inspiring conversations. Here are some of them: 🌎 A blog on how we align our innovations with global sustainability goals. ✅ The key considerations in selecting the right AI solutions to improve patient outcomes. 🏥 A critical debate on population-based screening for prostate cancer, highlighting current solutions to make testing more affordable and accessible lead by Prof. Dr. Shonit Punwani from UCL. 💻 QP-Prostate® used by experts in real-world scenarios. 🔊 The announcement of our activities and contributions as we get ready for the ESMO - European Society for Medical Oncology conference. Stay up to date on the latest developments in #patientcare, #medicalimaging and #radiology in our monthly newsletter. Sign up to be updated!
-
🗓️ In two weeks, from September 13-17, our #QuibimTeam will be in Barcelona for the world-leading oncology event: #ESMO2024! 👋🏻 Say hi to booth #526 and discover through our market-approved solution QP-Insights® the latest advancements in #oncology, medical imaging, and #PatientCare. https://lnkd.in/dirKEMU8 #cancercare
-
-
In a recent webinar, Prof. Kai Vilanova MD, PhD analyzed a clinical case initially rated with a PI-RADS score 3. After reviewing the DCE images, he raised the score to 4, but QP-Prostate® did not detect any lesions. Further review and biopsy confirmed that QP-Prostate® was correct, diagnosing the case as prostatitis. This case highlights the critical role of advanced diagnostic tools and the importance of continuous learning in radiology. ▶ Watch the full webinar here: https://bit.ly/3wSrNfo
-
✅ QP-Liver uses advanced #AI algorithms to quantify hepatic fat and iron from #MRI scans, facilitating early detection and formulating more personalized treatment plans. Improving clinical decision-making, QP-Liver reduces the need for traditionally invasive biopsies, thereby improving #patientcare by providing accurate, non-invasive diagnostics. CE marked (MDR) and UKCA approved, the software is currently available in Europe and the UK 🙌🏻 Full details are disclosed here: https://lnkd.in/dTAt-ie2 #HepaticDiseases #MedicalImaging #HealthInnovation
-
🌎 Helping each other grow both professionally and personally every day is one of our greatest strengths as a multicultural team. Best of all, while doing so, we actively contribute to driving innovation in the medical imaging and healthcare industry, fostering improved patient care 💙 #quibimteam #healthcareinnovation #medicalimaging
-
As partners in the European Federation for Cancer Images (EUCAIM), we are more than proud to say that we are contributing every day to an important step forward in the fight against #cancer. With the launch of this project, the European Commission is creating a federated imaging #data infrastructure that could improve outcomes for #oncology patients worldwide. Don't miss the latest news on this transformative initiative ⬇
📰 Curious about the progress of #EUCAIM in the last 18 months? 🤔 No need to look further! Our latest newsletter is here, packed with the main achievements from the first 18 months and provides fresh updates on the project 🌠 Read it now here 👉 https://lnkd.in/ejPDP5Pt #DigitalEurope #EUfunded
-
-
New evidence supporting the need to add #AI as the perfect companion to radiologists. Fatigue, feeling hungry, and cyrcadian rythms can introduce overdiagnosis of #ProstateCancer towards the end of the shift. The analysis of 35,000 MRI reports over eight years shows a significant rise in malignancy scores later in the day, impacting patient outcomes. As we move toward integrating AI into clinical practice, do you think that this bias will remain? 👉 https://lnkd.in/d-zfTxk4
The “Hungry Judge” effect on prostate MRI reporting: Chronobiological trends from 35’004 radiologist interpretations
ejradiology.com
-
In the dynamically evolving field of healthcare #AI, protecting patient privacy through #data de-identification is more crucial than ever. In this recent paper, co-authored by Quibim and other leading experts, we explore the strategies used by five major European projects, Primage Project, The CHAIMELEON Project, ProCAncer-I project, #IncisiveEu and EuCanImage, to manage data de-identification. These are some main takeaways, but you can access the full details here 👉 https://lnkd.in/dt3pDV4F #AIinHealth #DataPrivacy #MedicalImaging #Quibim #HealthDataSecurity #InnovationInMedicine